Summary
A cannabis-based medicine formulated by a UK firm to help sufferers of multiple sclerosis has been approved for the first time - in Canada.
Sativex oral spray was given the go-ahead in Canada to treat neuropathic pain in adults with MS, GW pharmaceuticals and Bayer HealthCare has announced.See the full content of this document
Extract
Canada Approves Cannabis Ms Drug
The move has raised hopes that the drug will soon be available in the UK to thousands of patients, some o...
See the full content of this document
Sponsored links
